Nicotine Chewing Gum: Clinical Trials

101 trials of Nicotine Chewing Gum, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

72 completed, 8 terminated, 7 unknown, 6 not yet recruiting. 41 Not applicable, 26 Phase 4, 15 Phase 2, 13 Phase 3, 7 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable41Completed 31, Terminated 3, Unknown 3, Not yet recruiting 2, Active not recruiting 1, Recruiting 1
Phase 426Completed 16, Terminated 3, Not yet recruiting 2, Recruiting 2, Unknown 2, Active not recruiting 1
Phase 215Completed 11, Recruiting 2, Not yet recruiting 1, Terminated 1
Phase 313Completed 8, Unknown 2, Not yet recruiting 1, Recruiting 1, Terminated 1
Phase 17Completed 6, Not yet recruiting 1
Early Phase 15Completed 4, Withdrawn 1

Follow Nicotine Chewing Gum: new trials by email Literature Review of Nicotine Chewing Gum trials Research Report on Nicotine Chewing Gum

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Smoking Cessation Medication And Rewards Using a Teamlet to Treat Tobacco Use Disorder (SMARTTT 2.0) Among Persons With HIV: A Multi-site Hybrid Type 2 Effectiveness-implementation Trial
nicotine patch, nicotine gum, nicotine lozenge, varenicline, bupropion, Multi-target Contingency Management, Teamlet booster - Tobacco Use Disorder/Cigarette Smoking, HIV
Phase 4Not yet recruitingYale University7942027-09-302026-09-23
Evaluating an Innovative Tobacco Treatment Approach for Veterans in Substance Use Treatment
Healthy Changes Nicotine Replacement Therapy (NRT), Cessation Treatment Nicotine Replacement Therapy (NRT), Cessation Treatment Counseling - Cigarette Smoking, Veterans
Phase 4Not yet recruitingVA Office of Research and Development1122027-04-012026-09-14
Abstinence Reinforcement Therapy for Veterans Who Smoke Tobacco and Are Experiencing Homelessness
Cognitive Behavioral Therapy for Smoking Cessation, Nicotine Replacement Therapy, Bupropion - Tobacco Use Disorder
Not applicableNot yet recruitingVA Office of Research and Development1202027-03-012026-07-20
Acute Nicotine Gum and Auditory Brain Responses in Adults With Chronic Tinnitus
Nicotine polacrilex gum 4 mg, Placebo gum - Tinnitus, Chronic Subjective Tinnitus
Phase 1 / Phase 2Not yet recruitingXianhui Wang202026-11-012026-10-21
iCanQuit Smoking Cessation Among Hispanic Adults
iCanQuit Smartphone App Smoking Cessation Program, Nicotine Gum, Nicotine Patch - Cigarette Smoking-Related Carcinoma
Phase 3Not yet recruitingFred Hutchinson Cancer Center8542026-10-152026-09-21
Varenicline for Smoking Reduction in Veterans Not Ready To Quit
Motivation-Phase Varenicline, Motivation-Phase Nicotine Mini-Lozenge, Cessation-Phase Combination Nicotine Replacement Therapy (NRT) - Veterans, Tobacco Use Disorder
Phase 4RecruitingVA Office of Research and Development4002026-08-172026-08-31
Gen AI Powered Behavioral Support Plus Chewing Gum Intervention for Construction Workers Who Smoke
AWARD advice, Brief leaflet on health warning and smoking cessation, Referral card - Smoking Cessation
Not applicableNot yet recruitingThe University of Hong Kong2002026-06-202026-06-17
Acute Nicotine Gum and Tinnitus Loudness in Non-Smoking Adults
Nicotine polacrilex gum 4 mg, Placebo gum - Tinnitus, Chronic Subjective Tinnitus
Phase 1 / Phase 2CompletedSan Diego State University292026-03-252026-10-16
Adaptive Use of Nicotine Substitution to Maintain Smoking Reduction/Abstinence in Nicotine Responders
Nicoderm, Nicorette 4Mg Chewing Gum, Nicorette Lozenge Product - Smoking Cessation, Harm Reduction
Phase 3CompletedRose Research Center, LLC1502024-08-292026-02-06
Smoking Cessation Program in the Construction Sector
Nicorette, Tobacco Quit-line, Brief Behavioral Counseling - Smoking Cessation, Tobacco Use Cessation
Phase 4Active not recruitingUniversity of Miami6082024-04-102026-08-21
Pharmacokinetic and Subjective Effects of Heated Tobacco Products
Product A, Product B, Product C - Tobacco Use
Not applicableCompletedAltria Client Services LLC802024-02-062026-03-27
Effects of Caffeine and Nicotine Gum on Balance Performance in Athletes
Caffeine Gum 3mg/kg, Nicotine Gum (4 mg), Placebo Gum (Xylitol) - Athletic Performance, Postural Stability
Not applicableCompletedGülbin Rudarlı202024-01-082025-12-04
Evaluate Harm Reduction Products as a Second Line Intervention for Adult Smokers Who Do Not Quit With NRT
Nicoderm, Nicorette 4Mg Chewing Gum, Nicorette Lozenge Product - Smoking Cessation, Harm Reduction
Phase 3TerminatedRose Research Center, LLC42023-12-272025-03-30
Evaluating Smoking Cessation Interventions for PWH in South Africa
Varenicline, Nicotine patch, Nicotine gum - Smoking Cessation, HIV
Phase 2 / Phase 3RecruitingJohns Hopkins University6602023-11-272026-10-19
Neuroimaging Correlates and Feasibility of Transcranial Magnetic Stimulation (TMS) to Improve Smoking Cessation Outcomes in Veterans With Comorbid PTSD
active repetitive transcranial magnetic stimulation, sham repetitive transcranial magnetic stimulation, cognitive behavioral therapy for smoking cessation - Tobacco Use Disorder
Phase 2RecruitingVA Office of Research and Development502023-10-312026-02-18
BREATHE 2 Clinic Stop-Smoking Treatment Outreach Study
Text message smoking treatment, Nicotine replacement therapy sampling, Wisconsin Tobacco QuitLine Referral - Quitting Smoking, Smoking Cessation
Phase 4CompletedUniversity of Wisconsin, Madison123762023-07-242026-06-26
Smoking Cessation and Menstrual Cycle Phase
Timing of nicotine replacement therapy start date, Nicotine Replacement Therapy Agent - Nicotine Dependence, Tobacco Smoking
Phase 4RecruitingCentre for Addiction and Mental Health12002022-11-302026-03-19
Effects of Nicotine and Attention on Frequency Tuning in Auditory Cortex
Nicotine gum, Placebo gum - Aging
Early Phase 1CompletedUniversity of California, Berkeley442022-06-062026-07-24
Easy Access to Smoking Cessation for People Receiving Opioid Agonist Therapy Who Are Smoking Tobacco
Nicotine patch, Nicotine gum, Nicotine lozenge - Smoking Cessation, Substance-Related Disorders
Not applicableActive not recruitingHaukeland University Hospital2662022-04-072024-06-28
WeChat Quit Coach Pilot Study
WeChat Quit Coach, Leaflet, Optional Nicotine Replacement Therapy (NRT) Patches or Lozenges - Smoking Cessation
Not applicableCompletedNYU Langone Health1502022-02-102026-07-31

Showing 20 of 101. Sign in to see all of them.

Conditions studied

Smoking Cessation (55)  ·  Tobacco Use Disorder (33)  ·  Smoking (21)  ·  Cigarette Smoking (9)  ·  Tobacco Use Cessation (7)  ·  Tobacco Use (6)  ·  Harm Reduction (5)  ·  Schizophrenia (5)  ·  Tobacco Smoking (4)  ·  Vaping (4)  ·  Alcohol Drinking (3)  ·  Psychotic Disorders (3)  ·  Substance-Related Disorders (3)  ·  Body Weight (2)  ·  Depression (2)

Sponsors

McNeil AB (9)  ·  Duke University (8)  ·  VA Office of Research and Development (6)  ·  University of Minnesota (4)  ·  University of Wisconsin, Madison (4)  ·  Centre for Addiction and Mental Health (3)  ·  Johns Hopkins University (3)  ·  National Institute on Drug Abuse (NIDA) (3)  ·  Yale University (3)  ·  22nd Century Group, Inc. (2)  ·  Mark Vander Weg (2)  ·  Rose Research Center, LLC (2)  ·  The University of Hong Kong (2)  ·  University of Kansas Medical Center (2)  ·  University of Miami (2)

Countries

United States (68)  ·  Sweden (8)  ·  Canada (4)  ·  South Africa (3)  ·  China (2)  ·  Czechia (1)  ·  Denmark (1)  ·  Finland (1)  ·  France (1)  ·  Greece (1)  ·  Hong Kong (1)  ·  Japan (1)  ·  Jordan (1)  ·  Norway (1)  ·  Spain (1)

Top investigators

Elisabeth Kruse, PhD (8)  ·  A Eden Evins, MD, MPH (2)  ·  Debra Kelsh, MD (2)  ·  Dorothy Hatsukami, Ph.D. (2)  ·  E. Jennifer Edelman, MD, MHS (2)  ·  Jean C Beckham, Ph.D. (2)  ·  Jean C Beckham, PhD (2)  ·  Jean C. Beckham, Ph.D. (2)  ·  Stephen I Rennard, MD (2)  ·  Taghrid Asfar, MD (2)  ·  Xianhui Wang (2)  ·  Amanda L Graham, PhD (1)  ·  Amy J Arouni, MD (1)  ·  Claudio M Pannuti, PhD (1)

Results publications

PMID 37142273, PMID 37335995, PMID 37230961, PMID 17632223, PMID 17763111, PMID 17888856, PMID 19392908, PMID 19664750, PMID 21561497, PMID 21605389, PMID 22992296, PMID 24329972, PMID 24794687, PMID 25005652, PMID 25699616, PMID 27535024, PMID 27918881, PMID 28288601, PMID 28549278, PMID 28806908, PMID 29454141, PMID 29878062, PMID 30646142, PMID 30664539, PMID 31426671, PMID 31619205, PMID 31832719, PMID 33063570, PMID 33794354, PMID 34255698, PMID 34611902, PMID 35196033, PMID 35435813, PMID 35978355, PMID 36848129, PMID 37005655, PMID 37285107, PMID 37639601, PMID 37889541, PMID 38184633, PMID 38409089, PMID 39037756, PMID 39665734, PMID 39868569, PMID 39937506, PMID 40489501, PMID 40543725, PMID 41758512

NIH funding

2008 (4), R01AG067073 (2), 1RC1CA144382-01 (1), 2009 (1), K01MD014165 (1), P01CA180945 (1), P50CA143188 (1), P50DA013333 (1), R01AA011197 (1), R01CA135884 (1), R01CA155489 (1), R01CA174481 (1), R01CA243910 (1), R01CA298383 (1), R01DA002538 (1)